Index RUT P/E 49.31 EPS (ttm) 0.11 Insider Own 2.89% Shs Outstand 306.33M Perf Week -3.23%
Market Cap 1.65B Forward P/E 40.15 EPS next Y 0.13 Insider Trans -3.49% Shs Float 297.97M Perf Month 41.47%
Enterprise Value 1.63B PEG 2.31 EPS next Q 0.03 Inst Own 55.45% Short Float 5.33% Perf Quarter 43.73%
Income 32.80M P/S 5.48 EPS this Y 17.53% Inst Trans -3.40% Short Ratio 3.90 Perf Half Y 3.45%
Sales 301.74M P/B - EPS next Y 14.23% ROA 7.67% Short Interest 15.89M Perf YTD -16.17%
Book/sh -0.18 P/C 9.24 EPS next 5Y 21.32% ROE - 52W High 7.63 -29.36% Perf Year -14.04%
Cash/sh 0.58 P/FCF 58.60 EPS past 3/5Y - - ROIC 66.81% 52W Low 3.38 59.41% Perf 3Y 35.43%
Dividend Est. - EV/EBITDA 19.57 Sales past 3/5Y 55.84% 35.27% Gross Margin 74.91% Volatility 4.99% 5.34% Perf 5Y 224.70%
Dividend TTM - EV/Sales 5.39 EPS Y/Y TTM 162.30% Oper. Margin 24.11% ATR (14) 0.29 Perf 10Y -70.55%
Dividend Ex-Date - Quick Ratio 2.24 Sales Y/Y TTM 21.48% Profit Margin 10.87% RSI (14) 63.64 Recom 1.00
Dividend Gr. 3/5Y - - Current Ratio 2.50 EPS Q/Q 128.38% SMA20 8.34% Beta 1.07 Target Price 10.57
Payout 0.00% Debt/Eq - Sales Q/Q 5.72% SMA50 26.00% Rel Volume 0.63 Prev Close 5.37
Employees 407 LT Debt/Eq - Earnings Aug 06 BMO SMA200 8.58% Avg Volume 4.07M Price 5.39
IPO Jul 28, 2004 Option/Short Yes / Yes EPS/Sales Surpr. -100.00% -2.87% Trades
Volume 2,575,885 Change 0.37%
Date
Action
Analyst
Rating Change
Price Target Change
Jul-16-25 Resumed H.C. Wainwright
Buy
$9
Apr-10-25 Initiated Mizuho
Outperform
$12
Feb-10-25 Initiated Wedbush
Outperform
$11
Dec-20-24 Initiated Wells Fargo
Overweight
$9
Dec-19-24 Upgrade RBC Capital Mkts
Sector Perform → Outperform
$7 → $10
Sep-09-24 Resumed Leerink Partners
Outperform
$7 → $8
Jun-13-24 Initiated Rodman & Renshaw
Buy
$8
Oct-10-23 Initiated Wedbush
Outperform
$10
May-14-21 Initiated RBC Capital Mkts
Sector Perform
$5
Dec-24-19 Initiated Oppenheimer
Outperform
$2.50
Oct-25-19 Initiated Cantor Fitzgerald
Overweight
$3
May-14-19 Initiated BTIG Research
Buy
$3
Mar-04-19 Initiated SVB Leerink
Outperform
$3
Feb-22-19 Initiated SVB Leerink
Outperform
$3
Feb-28-18 Downgrade Maxim Group
Hold → Sell
$1
Nov-01-17 Downgrade Maxim Group
Buy → Hold
Oct-10-17 Initiated H.C. Wainwright
Buy
$7
Oct-06-17 Reiterated Maxim Group
Buy
$4 → $7
Aug-11-17 Initiated Maxim Group
Buy
$4
May-10-16 Reiterated RBC Capital Mkts
Underperform
$0.15 → $0.20
Show Previous Ratings
Sep-10-25 11:30AM
Sep-02-25 10:30AM
(Associated Press Finance) +25.05%
Aug-31-25 12:16AM
Aug-29-25 09:38AM
05:10AM
04:05PM
Loading…
Aug-27-25 04:05PM
08:05AM
04:46AM
Aug-25-25 11:56PM
07:30AM
Aug-22-25 11:45PM
Aug-17-25 06:26PM
Aug-06-25 09:30AM
08:25AM
07:10AM
07:05AM
Loading…
07:05AM
Aug-05-25 09:56AM
Aug-04-25 10:01AM
Aug-01-25 06:46AM
Jul-31-25 10:00AM
Jul-30-25 04:05PM
10:00AM
Jul-28-25 02:27AM
Jul-23-25 11:25AM
Jul-17-25 11:11AM
Jul-11-25 11:28AM
Jul-07-25 09:10AM
Jun-25-25 09:28AM
Jun-24-25 03:52PM
Jun-23-25 12:16PM
04:05PM
Loading…
Jun-09-25 04:05PM
May-27-25 09:15AM
May-13-25 04:05PM
May-09-25 10:31AM
May-08-25 09:25AM
08:21AM
(Associated Press Finance)
08:05AM
May-07-25 12:32PM
10:12AM
May-05-25 04:06PM
May-01-25 04:05PM
Apr-18-25 10:00AM
Apr-16-25 11:17AM
Apr-07-25 12:30PM
Mar-10-25 06:05AM
Feb-27-25 02:19AM
12:30AM
Feb-26-25 07:30PM
06:15PM
05:08PM
(Associated Press Finance)
04:05PM
Feb-25-25 10:30AM
Feb-24-25 09:16AM
Feb-19-25 04:05PM
Feb-06-25 04:05PM
Jan-06-25 04:30PM
08:47AM
Dec-18-24 07:00AM
Dec-16-24 06:05AM
Dec-11-24 06:00AM
Nov-08-24 01:26PM
(Thomson Reuters StreetEvents)
02:28AM
Nov-07-24 11:15PM
07:00PM
05:40PM
04:34PM
(Associated Press Finance)
04:02PM
Nov-06-24 07:17AM
Nov-05-24 04:15PM
Nov-04-24 06:05AM
Nov-01-24 09:15AM
Oct-31-24 04:05PM
Oct-30-24 09:00PM
Oct-09-24 05:13PM
Oct-07-24 12:10PM
Oct-04-24 09:35AM
Sep-30-24 08:01AM
06:00AM
Sep-21-24 02:47AM
Sep-18-24 06:15AM
Sep-15-24 07:21PM
Sep-10-24 04:30PM
Sep-05-24 01:33AM
Aug-31-24 01:42AM
Aug-27-24 04:30PM
Aug-14-24 08:00AM
Aug-09-24 09:40AM
Aug-07-24 04:45PM
09:30AM
09:10AM
08:08AM
(Associated Press Finance)
08:00AM
Jul-31-24 06:30AM
Jul-30-24 04:30PM
Jul-16-24 12:00PM
09:40AM
09:15AM
Jun-22-24 08:00AM
Jun-05-24 06:45AM
May-29-24 08:45AM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tross Stuart A Chief People & Workpl Officer Sep 16 '25 Sale 5.34 47,000 250,980 1,032,013 Sep 17 07:39 PM STUART A TROSS Officer Sep 16 '25 Proposed Sale 5.34 47,000 250,792 Sep 16 04:05 PM Binder Steven B. Director Jul 16 '25 Sale 3.94 75,367 296,946 830,508 Jul 17 08:51 PM Thomson David EVP Genl Counsel & Secretary Jul 16 '25 Sale 3.94 7,466 29,416 841,719 Jul 17 08:46 PM DAVID THOMSON Officer Jul 16 '25 Proposed Sale 3.94 7,466 29,427 Jul 16 04:10 PM STEVEN B BINDER Director Jul 16 '25 Proposed Sale 3.94 75,367 296,645 Jul 16 04:04 PM Binder Steven B. Director Jun 10 '25 Sale 4.00 64,085 256,340 925,258 Jun 10 08:07 PM STEVEN B BINDER Director Jun 10 '25 Proposed Sale 4.00 64,085 256,430 Jun 10 04:02 PM Binder Steven B. Director May 20 '25 Sale 4.40 12,078 53,143 989,343 May 20 09:45 PM Thomson David EVP Genl Counsel & Secretary May 20 '25 Sale 4.41 2,345 10,341 879,546 May 20 09:44 PM DAVID THOMSON Officer May 20 '25 Proposed Sale 4.41 2,345 10,334 May 20 04:14 PM STEVEN B BINDER Director May 20 '25 Proposed Sale 4.40 12,078 53,184 May 20 04:03 PM Thomson David EVP Genl Counsel & Secretary May 13 '25 Sale 4.68 32,179 150,598 772,427 May 15 09:37 PM Binder Steven B. Director May 13 '25 Sale 4.69 80,144 375,875 1,006,611 May 15 09:35 PM STEVEN B BINDER Director May 13 '25 Proposed Sale 4.69 80,144 375,499 May 13 04:03 PM DAVID THOMSON Officer May 13 '25 Proposed Sale 4.68 32,179 150,717 May 13 04:02 PM Binder Steven B. Director Nov 22 '24 Option Exercise 1.47 67,536 99,278 1,142,562 Nov 25 09:30 PM Binder Steven B. Director Nov 22 '24 Sale 6.89 67,536 465,323 1,075,026 Nov 25 09:30 PM STEVEN B BINDER Director Nov 22 '24 Proposed Sale 6.89 67,536 465,397 Nov 22 04:08 PM Binder Steven B. Director Nov 15 '24 Option Exercise 1.47 67,539 99,282 1,142,565 Nov 19 09:30 PM Binder Steven B. Director Nov 15 '24 Sale 6.76 67,539 456,564 1,075,026 Nov 19 09:30 PM STEVEN B BINDER Officer Nov 15 '24 Proposed Sale 6.76 67,539 456,793 Nov 15 04:01 PM Tross Stuart A Chief People & Workpl Officer Nov 06 '24 Sale 7.34 55,000 403,700 967,191 Nov 08 09:30 PM STUART A TROSS Officer Nov 06 '24 Proposed Sale 7.34 55,000 403,700 Nov 06 04:04 PM
